A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07719361 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer
mCRPC
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
mCRPC or Advanced/Metastatic Solid Tumors
mCRPC, Metastatic Castration Resistant Prostate Cancer
Neoplasms Prostate
Neoplasms of Prostate

Interventions

DRUG: FX-111

Sponsor

Flare Therapeutics Inc.